Patients should be advised to: Start with the lowest dose and increase slowly Eat smaller, more frequent meals Avoid high-fat foods Stay well-hydrated Safety monitoring should include vigilance for: Pancreatitis symptoms (severe persistent abdominal pain) discontinue immediately if suspected Gallbladder disease increased risk with rapid weight loss Hypoglycaemia particularly when combined with insulin or sulphonylureas Renal function deterioration especially with dehydration from gastrointestinal effects Diabetic retinopathy monitor in patients with pre-existing retinopathy, particularly with semaglutide Suspected adverse reactions should be reported via the MHRA Yellow Card scheme
Now, as I say, all of this for people who are definitely GLP one skeptics, I want you to know the goal is not just a smaller body, it's a strong body
Brzozowski T, Kwiecien S, Konturek PC, et al
Rotating injection sites and proper injection techniques can help minimize these reactions
Firstly, anticancer peptides have exhibited weak targeted treatment for breast cancer
